Search hospitals > Florida > Daytona Beach
International Medical Research
Claim this profileDaytona Beach, Florida 32117
Conducts research for Rheumatoid Arthritis
Conducts research for Arthritis
Conducts research for Alzheimer's Disease
Conducts research for Dementia
Conducts research for Alzheimer's Dementia
39 reported clinical trials
0 medical researchers
Summary
International Medical Research is a medical facility located in Daytona Beach, Florida. This center is recognized for care of Rheumatoid Arthritis, Arthritis, Alzheimer's Disease, Dementia, Alzheimer's Dementia and other specialties. International Medical Research is involved with conducting 39 clinical trials across 46 conditions. There are 0 research doctors associated with this hospital, such as .Area of expertise
1Rheumatoid Arthritis
Rheumatoid factor positive
Anti-cyclic citrullinated peptide autoantibodies positive
ACPA positive
2Arthritis
Rheumatoid factor positive
Anti-cyclic citrullinated peptide autoantibodies positive
ACPA positive
Top PIs
Clinical Trials running at International Medical Research
Alzheimer's Disease
Mild Cognitive Impairment
Alzheimer's Dementia
Dementia
Cognitive Impairment
Type 2 Diabetes
Rheumatoid Arthritis
Diabetes
Acute Coronary Syndrome
Syndrome
Sensory Stimulation
for Alzheimer's Disease
This trial is testing a device that uses light and sound to help patients with mild to moderate Alzheimer's disease. The goal is to see if this sensory stimulation can slow down the progression of the disease by improving brain function. This therapy has shown potential for application in the treatment of Alzheimer's disease.
Recruiting0 awards N/A1 criteria
ACP-204
for Alzheimer's Disease
This is a master protocol for 3 independent, seamlessly enrolling, multicenter, randomized, double-blind, placebo-controlled, parallel-group studies in patients with ADP Substudy 1 (Phase 2) will evaluate efficacy and dose response of ACP-204 30 and 60 mg vs placebo. This substudy will be initiated first. Substudies 2A and 2B (both: Phase 3) will be confirmatory studies of either both doses (ACP-204 30 and 60 mg, respectively) or a single dose from Part 1 vs placebo. Substudies 2A and 2B will be performed independently of each other and will commence after enrollment of Part 1. All 3 substudies will be analyzed independently of each other. Each substudy individually will consist of a screening period (up to 42 days); a double-blind treatment period (6 weeks); a safety follow-up period (30 days) for patients not rolling over into an open-label extension study; and vital status follow-up (for patients who terminated their substudy early).
Recruiting0 awards Phase 2 & 31 criteria
BMS-986446
for Early Alzheimer's Disease
This trial is testing a new medication called BMS-986446 in people with early Alzheimer's disease. The medication is designed to target harmful proteins in the brain to slow down the disease. Researchers are checking if it works well and is safe for patients.
Recruiting0 awards Phase 2
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at International Medical Research?
International Medical Research is a medical facility located in Daytona Beach, Florida. This center is recognized for care of Rheumatoid Arthritis, Arthritis, Alzheimer's Disease, Dementia, Alzheimer's Dementia and other specialties. International Medical Research is involved with conducting 39 clinical trials across 46 conditions. There are 0 research doctors associated with this hospital, such as .